Sensitivity and specificity of increased pulse pressure as a diagnostic test for K/DOQI stage III-b CKD

Ana I Pérez-Castañeda1, Gilberto F Vázquez-de Anda1, Patricia Cerecero-Aguirre1

  • 1Multidisciplinary Health Clinic, Universidad Autónoma del Estado de México, State of Mexico. Mexico.

Gaceta Medica De Mexico
|December 29, 2020
PubMed

Insights

Increased pulse pressure (IPP) can help identify chronic kidney disease (CKD) stage III-b. An IPP of 50 mmHg or higher demonstrated high accuracy in diagnosing this condition.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Diagnostic Testing

Background:

  • Increased pulse pressure (IPP) is linked to estimated glomerular filtration rates ≤ 60/mL/min/1.73 m².
  • IPP may serve as a diagnostic marker for identifying individuals with K/DOQI stage III-b chronic kidney disease (CKD).

Purpose of the Study:

  • To evaluate the diagnostic utility of IPP for K/DOQI stage III-b CKD.

Main Methods:

  • A diagnostic test study involving adult patients without comorbidities from the Health Workers Cohort.
  • Glomerular filtration was calculated using the CKD-EPI formula.
  • Pulse pressure was calculated as systolic minus diastolic blood pressure. Sensitivity, specificity, predictive values, and prevalence were determined, and a ROC curve was generated.

Main Results:

  • The study included 6,215 patients.
  • An IPP ≥ 50 mmHg showed 74% sensitivity and 70% specificity.
  • The positive predictive value was 1%, the negative predictive value was 100%, and the prevalence was 1%. The ROC curve's inflection point for identifying K/DOQI III-b CKD was 0.71.

Conclusions:

  • An IPP ≥ 50 mmHg is a valuable diagnostic tool for identifying individuals with K/DOQI stage III-b CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
207
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
357
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
141
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
81
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
221
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
156